 |
|
|
| |
Increased Baseline Comorbidity Burden Among Commercially Insured Patients With Hepatitis Delta Virus Infection vs Hepatitis B Virus Monoinfection in the United States
|
| |
| |
EASL 2023 June 21-23 Vienna
Robert G Gish1, Robert J Wong2,3, Chong Kim4, Gary Leung5, Ira M Jacobson6, Joseph K Lim7, Ankita Kaushik4
1Hepatitis B Foundation, Doylestown, PA, USA; 2Stanford University School of Medicine, Stanford, CA, USA; 3VA Palo Alto Healthcare System, Palo Alto, CA, USA; 4HEOR - Global Value & Access, Gilead Sciences, Inc., Foster City, CA, USA; 5RWE - Epidemiology, Gilead Sciences, Inc., Foster City, CA, USA; 6NYU Grossman School of Medicine, New York, NY, USA; 7Yale University School of Medicine, New Haven, CT, USA
|
| |
|
|
|
|
|
